Fiasp 100 E/ml ultra-fast-acting PumpCart
Fiasp 100 E/ml ultra-fast-acting PumpCart is a medicine authorised by Swissmedic under authorisation number 67809. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 February 2021 and the authorisation is limited until 31 March 2027. ATC code A10AB05 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 67809 |
|---|---|
| Name | Fiasp 100 E/ml ultra-fast-acting PumpCart |
| Full name | Fiasp 100 E/ml ultra-fast-acting PumpCart, Injektionslösung in einer Patrone |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AB05 |
| First authorisation | 18 February 2021 |
| Authorisation validity | 31 March 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fiasp 100 E/ml ultra-fast-acting PumpCart, Injektionslösung in einer Patrone | B | 18 February 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 1.6 | ml | A10AB05 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fiasp 100 E/ml ultra-fast-acting PumpCart authorised in Switzerland?
Yes. Fiasp 100 E/ml ultra-fast-acting PumpCart is authorised by Swissmedic under authorisation number 67809, data as of 01 September 2026. The authorisation is limited until 31 March 2027.
Which dispensing category does Fiasp 100 E/ml ultra-fast-acting PumpCart have?
Fiasp 100 E/ml ultra-fast-acting PumpCart is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Fiasp 100 E/ml ultra-fast-acting PumpCart?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.